CXC趋化因子配体10与病毒性肝炎研究进展
[Abstract]:In the progress of viral hepatitis disease, lymphocyte migration and infiltration into the infected liver tissue, anti-viral immune response and inflammatory response plays a vital role. However, the study of its mechanism has not yet obtained a satisfactory answer. In recent years, CXC chemokine ligand (CXC chemokine ligand,CXCL) 10 is one of the most widely studied cytokines. Its receptor is an important breakthrough point of the mechanism of occurrence and development of viral hepatitis. This article reviews the significance of CXCL10 in viral hepatitis and the related research progress in the evaluation of antiviral efficacy. CXCL10, also known as interferon 纬 inducible protein 10, belongs to the ELR- chemokine in the CXC subfamily. CXCL10 mainly binds to chemokine receptor CXCR3. Its main functions include promoting cell chemotaxis, inducing apoptosis, regulating cell growth and proliferation, and regulating angiogenesis. A number of studies have shown that the expression of CXCL10 in serum and liver tissues of chronic HBV,HCV infected patients increased, and with the severity of liver inflammation and fibrosis, the level of CXCL10 also increased. The results suggest that CXCL10 may play an important role in the process of liver pathological injury. The level of serum CXCL10 decreased gradually after treatment with antiviral HBV,HCV drugs, suggesting that CXCL10 may play an important role in the process of virus clearance. It was found that the baseline level of serum CXCL10 and the decrease of CXCL10 in the course of treatment might be effective in predicting the antiviral effect. However, the mechanism of CXCL10 involved in the pathological process of viral hepatitis and its role in antiviral therapy are still unclear, and need to be further studied.
【学位授予单位】:河北医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R512.6
【参考文献】
相关期刊论文 前10条
1 郝洁;田小军;宋新文;申保生;段树鹏;;聚乙二醇干扰素对慢性丙肝患者血清炎症细胞因子及抗体水平的影响[J];山东医药;2016年40期
2 张健;吴友伟;吕飒美;史丽萍;周健;;血清IP-10 MIG IL-8及RANTES水平变化与肝癌进展关系分析[J];西部医学;2015年09期
3 苏然;熊亚莉;刘勇;黄睿;王贵阳;严晓敏;陈军浩;吴超;;不同免疫状态下慢性HBV感染者外周血调节性B细胞及血清IL-10和IP-10的表达特点[J];中华实验和临床感染病杂志(电子版);2015年04期
4 李晓阳;张强;易显富;袁情;唐文娟;;趋化因子CXCL10启动子区-201G/A多态性与慢性乙型肝炎易感相关性研究[J];海南医学;2015年14期
5 王可宁;杨红园;褚瑞海;刘松;曲孝阳;;血清趋化因子IP-10在慢性HBV感染者中的表达及意义[J];辽宁医学院学报;2015年02期
6 Francesca Capone;Eliana Guerriero;Giovanni Colonna;Patrizia Maio;Alessandra Mangia;Giuseppe Castello;Susan Costantini;;Cytokinome profile evaluation in patients with hepatitis C virus infection[J];World Journal of Gastroenterology;2014年28期
7 王亚东;张莉;申川;曹伟;赵亚娟;甄真;赵彩彦;;慢性乙型肝炎病毒感染者不同阶段γ干扰素及其诱导蛋白10表达变化[J];中华传染病杂志;2014年01期
8 李文莉;吴茂盛;黄育波;朱计芬;刘细玲;许瑞荣;;干扰素α-2b对慢性乙型肝炎患者血清干扰素诱导蛋白、活性调节蛋白水平的影响[J];中国基层医药;2012年09期
9 杨华;罗亚文;刘华庆;侯文;李佳;;慢性乙型肝炎患者肝组织CXCR3及其配体IP 10表达与肝脏炎症程度、纤维化的相关性研究[J];第三军医大学学报;2012年03期
10 李绍民;刘国华;邓李玲;;替比夫定对慢性乙型肝炎患者外周血IP-10、Fractalkine水平影响及其临床意义的探讨[J];黑龙江医药科学;2012年01期
,本文编号:2369103
本文链接:https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/2369103.html